SOPHiA GENETICS SA
SOPHHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeSOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company carries a $492.5M market cap, placing it firmly in the small-cap category. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Market Cap
$492.5M
Beta
0.96
P/E (TTM)
—
P/E (Fwd)
-10.48
EPS (TTM)
$-1.18
EPS (Fwd)
$-0.56
ROE
-123.3%
ROA
-29.7%
Cash
$65.4M
Total Debt
$62.4M
Free CF
-$24.6M
52W Change
57.8%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $65.4M in cash comfortably exceeding the $62.4M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow is running at -$24.6M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -123.3% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $40.5M (2021) to $77.3M (2025), reflecting a 91% increase over the period.
The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing SOPH's risk profile alongside its fundamentals and technical indicators provides a more complete picture.